Minamoto A, Yamada T, Shimada S, Kinoshita I, Aoki Y, Oda K, et al. Current status and issues related to secondary findings in the first public insurance covered tumor genomic profiling in Japan: multi-site questionnaire survey. J Hum Genet. 2022;67:557–63. https://doi.org/10.1038/s10038-022-01028-x

Article  PubMed  Google Scholar 

Shimada S, Yamada T, Iwakuma M, Kosugi S. Physicians’ perceptions of the factors influencing disclosure of secondary findings in tumour genomic profiling in Japan: a qualitative study. Eur J Hum Genet. 2022;30:88–94. https://doi.org/10.1038/s41431-021-00944-4

Article  PubMed  Google Scholar 

Kawamura M, Shirota H, Niihori T, Komine K, Takahashi M, Takahashi S, et al. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: a retrospective analysis at a single facility. J Hum Genet. 2023;68:399–408. https://doi.org/10.1038/s10038-023-01133-5

Article  PubMed  CAS  Google Scholar 

Kage H, Oda K, Muto M, Tsuchihara K, Okita N, Okuma Y, et al. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan. Cancer Sci. 2023;114:3041–9. https://doi.org/10.1111/cas.15833

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kikuchi J, Ohhara Y, Takada K, Tanabe H, Hatanaka K, Amano T, et al. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan. Jpn J Clin Oncol. 2021;51:753–61. https://doi.org/10.1093/jjco/hyaa277. Erratum in: Jpn J Clin Oncol. 2022;52:1455

Article  PubMed  Google Scholar 

Sunami K, Naito Y, Aimono E, Amano T, Ennishi D, Kage H, et al. The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan. Int J Clin Oncol. 2021;26:443–9. https://doi.org/10.1007/s10147-020-01844-1. Epub 2021 Jan 1. Erratum in: Int J Clin Oncol. 2021;26:1007

Article  PubMed  PubMed Central  Google Scholar 

Sunami K, Naito Y, Komine K, Amano T, Ennishi D, Imai M, et al. Chronological improvement in precision oncology implementation in Japan. Cancer Sci. 2022;113:3995–4000. https://doi.org/10.1111/cas.15517

Article  PubMed  PubMed Central  CAS  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–8. https://doi.org/10.1136/bmj.39335.541782.AD

Article  Google Scholar 

O’Cathain A, Thomas KJ. “Any other comments?” Open questions on questionnaires—a bane or a bonus to research? BMC Med Res Methodol. 2004;4:25 https://doi.org/10.1186/1471-2288-4-25

Article  PubMed  PubMed Central  Google Scholar 

Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. London: SAGE Publications; 2013.

Tung N, Dougherty KC, Gatof ES, DeLeonardis K, Hogan L, Tukachinsky H, et al. Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing. NPJ Precis Oncol. 2023;7:76 https://doi.org/10.1038/s41698-023-00429-1

Article  PubMed  PubMed Central  Google Scholar 

Schrader KA, Cheng DT, Joseph V, Prasad M, Walsh M, Zehir A, et al. Germline variants in targeted tumor sequencing using matched normal DNA. JAMA Oncol. 2016;2:104–11. https://doi.org/10.1001/jamaoncol.2015.5208. Erratum in: JAMA Oncol. 2016;2(2):279. Doi: 10.1001/jamaoncol.2015.6541. Hyman, David [corrected to Hyman, David M]

Article  PubMed  PubMed Central  Google Scholar 

Cobain EF, Wu YM, Vats P, Chugh R, Worden F, Smith DC. et al.Assessment of clinical benefit of integrative genomic profiling in advanced solid tumors.JAMA Oncol.2021;7:525–33. https://doi.org/10.1001/jamaoncol.2020.7987

Article  PubMed  Google Scholar 

Stadler ZK, Maio A, Chakravarty D, Kemel Y, Sheehan M, Salo-Mullen E, et al. Therapeutic implications of germline testing in patients with advanced cancers. J Clin Oncol. 2021;39:2698–709. https://doi.org/10.1200/JCO.20.03661

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kuzbari Z, Bandlamudi C, Loveday C, Garrett A, Mehine M, George A, et al. Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations. Ann Oncol. 2023;34:215–27. https://doi.org/10.1016/j.annonc.2022.12.003

Article  PubMed  CAS  Google Scholar 

Nowlen CJ, Daniels M, Uzunparmak B, Ileana Dumbrava EE, Yuan Y, Patel KP, et al. Limited independent follow-up with germline testing of variants detected in BRCA1 and BRCA2 by tumor-only sequencing. J Immunother Precis Oncol. 2024;7:7–17. https://doi.org/10.36401/JIPO-23-2

Article  PubMed  PubMed Central  Google Scholar 

Catapano F, El Hachmi M, Ketterer-Heng N, Renieri A, Mari F, Morris M, et al. The role of the Genetic Counsellor in the multidisciplinary team: the perception of geneticists in Europe. Eur J Hum Genet. 2022;30:1432–8. https://doi.org/10.1038/s41431-022-01189-5. Epub 2022 Oct 5. Erratum in: Eur J Hum Genet. 2024;32:133

Article  PubMed  PubMed Central  Google Scholar 

Aizawa Y, Watanabe A, Kato K. Institutional and social issues surrounding genetic counselors in Japan: current challenges and implications for the global community. Front Genet. 2021;12:646177 https://doi.org/10.3389/fgene.2021.646177

Article  PubMed  PubMed Central  Google Scholar 

Japanese Board of Medical Genetics and Genomics, Clinical Genetics. List of clinical geneticists [Internet]. Japan; 2024 February 28 [cited 28 Feb 2024]. Available from: https://www.jbmg.jp/senmon/

Japanese Board of Certified Genetic Counselors. List of certified genetic counselors [Internet]. Japan: December 2023 [cited 28 Feb 2024]. Available from: https://plaza.umin.ac.jp/~GC/About.html

Muto K, Nagai A, Ri I, Takashima K, Yoshida S. Is legislation to prevent genetic discrimination necessary in Japan? An overview of the current policies and public attitudes. J Hum Genet. 2023;68:579–85. https://doi.org/10.1038/s10038-023-01163-z. Epub 2023 Jun 8. Erratum in: J Hum Genet. 2023

Article  PubMed  PubMed Central  Google Scholar 

Ryoshitu katu tekisetu na genomu iryou wo kokumin ga annshinnshite ukerareruyou ni surutame no shisaku no sougouteki katu keikakuteki na suishin ni kannsuru hourituann (Bill for an Act on Comprehensive and Systematic Promotion of Measures to Guarantee the Public’s Reliable Access to High-Quality Appropriate Genomic Medicine with Comfort) Shuho (Bills submitted by Members of House of Representatives) The 211th ordinary session of the Diet §18 (2023). https://www.shugiin.go.jp/internet/itdb_gian.nsf/html/gian/honbun/youkou/g21105018.htm

Ri I, Kawata J, Nagai A, Muto K. Expectations, concerns, and attitudes regarding whole-genome sequencing studies: a survey of cancer patients, families, and the public in Japan. J Hum Genet. 2023;68:281–5. https://doi.org/10.1038/s10038-022-01100-6. Epub 2022 Dec 12. Erratum in: J Hum Genet. 2022

Article  PubMed  Google Scholar 

Ministry of Health, Labour and Welfare. Action Plan for Whole Genome Analysis 2022 [document on internet]. Japan; 2022 September 30 [cited 28 Feb 2024]. Available from: https://www.mhlw.go.jp/content/10901000/001073173.pdf